Not investment advice. Origin reports data from public SEC filings with cryptographic provenance. No buy/sell/hold recommendations. Past performance does not indicate future results.
## Teradyne Holds $379 Floor as Analytical Interest Doubles — Pre-Earnings Signal Accumulation Phase
Price has settled at $379.65 on August 19, representing a modest pullback from the $381.40 peak noted in the June 20 observation, but still a 6.1% premium above the $357.93 initiation price. More notable is the acceleration in Origin AI queries: from 215 at the June 20 observation to 443 all-time — a doubling of analytical engagement in roughly two months. This is not price-driving data, but it confirms that the physical AI SAM expansion narrative and the ATE market share commitment are drawing sustained institutional and analytical scrutiny, not just initial curiosity. The price consolidation in the $379–$381 band, rather than retracement toward initiation levels, suggests the market is not dismissing the growth vectors identified across the 10-K's 121 strategic event matches. The filing signal architecture remains structurally unchanged — 7 AI adoption matches across multiple sections, 5 backlog growth signals, 5 restructuring signals — which means no new material disclosure has reset the analytical baseline. The critical gap remains transcript verification: only 1 transcript is captured, and the five management commitments (OPEX 27–29%, proportional midterm growth, ATE share gains, physical AI SAM expansion, labor shortage tailwinds) remain unconfirmed by actual quarterly results. The restructuring signal count of 5 deserves renewed attention — cost repositioning during a growth cycle can indicate either disciplined scaling or early margin defense. Watch for: Q2 2026 earnings release confirming or breaking the 27–29% OPEX band, any backlog figure disclosures, and whether restructuring activity correlates with segment-level margin compression.
## Teradyne Sustains Price Momentum as Analytical Interest Surges — Q2 Verification Remains the Pivotal Test
From the June 11 initiation at $357.93 through the June 20 observation at $381.40, Teradyne has now extended to $384.89 as of August 6 — a cumulative 7.5% appreciation since coverage began. More notable is the acceleration in Origin analytical interest: from 215 queries at the June 20 observation to 392 all-time today, an 82% increase in query volume. This suggests the physical AI and semiconductor test cycle narrative is attracting sustained analytical scrutiny, not just a one-time spike. The single transcript captured remains the anchor for management's quantitative commitments: OPEX at 27–29% of revenue, outperformance versus overall ATE market growth, and midterm proportional growth across groups. The filing signal structure is unchanged — 121 strategic event matches, 94 and 26 risk factor matches, and the 7+3+2 layered AI adoption signal pattern across distinct sections — reinforcing that no new 10-K filing has refreshed the data since initiation. This means the thesis remains in a verification gap: price is moving constructively, but the fundamental data confirming or challenging management's claims has not yet arrived. The 5 restructuring signals flagged in the 10-K deserve renewed attention, as restructuring activity during a growth narrative can indicate either cost-base optimization supporting the OPEX guidance or organizational friction beneath the surface. Watch for: Q2 2026 earnings transcript capture on Origin, which will be the first hard data point against every management commitment tracked since initiation. OPEX ratio and any ATE market share commentary are the primary verification targets.
## Teradyne Pulls Back from June Peak as Institutional Enthusiasm Tempers Into Earnings Proximity
The stock has retraced from the $381.40 high observed on June 20 to $367.69 as of July 31 — a 3.6% pullback that partially gives back the 6.6% surge noted in the prior observation. The retreat from peak levels, arriving as Q2 earnings proximity sharpens scrutiny, is a natural compression of the enthusiasm premium that had built around physical AI positioning. Notably, the stock still sits 2.7% above the $357.93 initiation price, meaning the structural thesis premium remains partially intact. AI queries on Origin have grown from 215 to 358 all-time — a 66% increase in analytical interest since coverage began — suggesting the investment community continues stress-testing the physical AI SAM expansion narrative even as price momentum moderates. The underlying filing signals remain static at 121 strategic event matches, 94 risk factor matches, and 7 AI adoption matches across the 10-K, with transcript language unchanged: the five core growth vectors (Compute, Defense, Photonics, high-speed internet/data centers, physical AI SAM), the proportional midterm growth claim across Groups, and the 27–29% OPEX guardrail are all still the primary accountability markers. With only one transcript captured, the dataset remains thin — Q2 earnings will be the first real test of whether ATE market share movement is materializing and whether OPEX discipline is holding within the guided band. Watch for: Q2 revenue attribution across the five stated growth vectors, any segment-level asymmetry that contradicts the "proportional growth" claim, and whether backlog signals convert to recognized revenue.
## Teradyne Pulls Back 15.9% From Recent High as Q2 Verification Moment Arrives
Since the June 20 observation logged Teradyne at $381.40, the stock has retraced sharply to $320.65 as of July 28 — a 15.9% drawdown that effectively erases the post-initiation momentum and brings price below the original $357.93 coverage entry. This is no longer a narrative-building phase; Q2 results are the first hard test of the commitments tracked from initiation. The OPEX guardrail of 27–29% of revenue, the ATE market share gain assertion, and the "proportional growth across each Group" claim all now face empirical scrutiny. The 315 all-time AI queries on Origin (up from 215 at the prior observation) confirms sustained analytical interest even as price softens, suggesting the thesis is being actively re-evaluated rather than abandoned. The restructuring signal is worth elevating at this juncture. The 5 restructuring matches in the 10-K were noted at initiation but subordinated to growth framing — a pullback of this magnitude warrants revisiting whether those signals foreshadowed cost actions that may now be materializing as margin pressure or headcount adjustments. The gap between the physical AI SAM narrative and near-term ATE cycle reality appears to be the friction the market is pricing. With only 1 transcript captured, the analytical record on management tone and guidance revision remains thin. Watch for: Q2 revenue against the ATE market growth rate benchmark, OPEX ratio versus the 27–29% band, and any restructuring disclosures that clarify whether the 10-K signals were proactive or reactive.
From $357.93 at initiation to $381.40 in the June 20 observation, and now $427.20 as of June 24 — Teradyne has appreciated 19.3% in thirteen days. This is no longer incremental drift; it represents a compression of the physical AI SAM expansion thesis into current price. The 64-point increase from the prior observation to today adds urgency to the Q2 verification question flagged at initiation: the market is now pricing in execution before the data arrives. Origin AI query volume has grown from 215 to 279 all-time, a 30% increase in four days, suggesting analytical interest is accelerating in parallel with price — both chasing the same unconfirmed catalysts. The filing signal structure remains static — 121 strategic event matches, 94 risk factor matches, 7 AI adoption matches — meaning no new disclosure has changed the informational picture. The move is sentiment and positioning, not fundamental update. This makes the upcoming Q2 2026 earnings report the highest-stakes data point in the coverage history so far. The three specific commitments remain the accountability anchors: ATE market share gains, OPEX within 27–29% of revenue, and proportional growth across Compute, Defense, Photonics, and data center segments. Watch for: any pre-announcement, guidance revision, or conference appearance before Q2 results that could either justify or deflate this valuation expansion. A miss on OPEX discipline or asymmetric segment performance would directly contradict the midterm symmetry claim and warrant reassessment.
Since initiating coverage at $357.93 on June 11, Teradyne's stock has moved to $381.40 — a 6.6% appreciation within the same session's data snapshot, suggesting intraday or intra-period institutional accumulation coinciding with the physical AI narrative gaining market traction. The 215 all-time AI queries on Origin indicates growing analytical interest in TER's positioning, consistent with the 7+ AI adoption signal matches across the 10-K that were flagged in the prior observation. Price momentum alone does not validate the thesis, but the direction aligns with the market beginning to price in the SAM expansion story management is explicitly constructing around physical AI, labor shortage tailwinds, and persistent semiconductor test demand. The data structure remains unchanged from initiation — same transcript facts, same filing signal counts — which means no new fundamental inputs have arrived to independently justify the price move. This is a critical distinction: the analytical guardrails established at initiation still hold. The OPEX band of 27–29% of revenue remains the primary execution metric to monitor, and the "proportional growth across each Group" commitment is still an unverified claim. The 5 restructuring signal matches in the 10-K deserve closer attention as revenue scales — restructuring language alongside growth guidance can signal cost base realignment that either supports or undermines operating leverage assumptions. Watch for: Q2 2026 earnings as the first hard data point against all five growth vectors; whether the $381 price level holds on any guidance nuance; and restructuring disclosure specificity in the next filing.
## Teradyne Initiates Coverage: Physical AI Tailwinds Meet Semiconductor Test Cycle Positioning
At $357.93 with a $49B market cap, Teradyne enters coverage at a notable inflection point. The 10-K filing density tells an immediate story: 121 strategic event matches and 94 risk factor matches signal a company actively repositioning its narrative around structural growth themes rather than purely cyclical semiconductor test demand. The 7 AI adoption signal matches — appearing across at least three distinct filing sections — confirm that physical AI is no longer peripheral language but is being woven into core strategic framing. Management's explicit expectation to grow revenue "greater than the overall ATE market growth rate" through share gains is a direct, trackable commitment that will be tested against each quarterly report. The transcript facts introduce a specific financial guardrail worth anchoring: OPEX guided at 27–29% of revenue. This range implies management expects operating leverage as revenue scales, and any sustained breach above 29% would signal either investment acceleration or execution friction. The growth thesis spans five distinct vectors — Compute, Defense, Photonics, high-speed internet/data centers, and physical AI SAM expansion — which diversifies the demand narrative but also complicates attribution when results arrive. The claim that midterm growth will be "proportional across each Group" is an unusually symmetric forecast that warrants scrutiny. Watch for: Q2 2026 earnings for first confirmation of ATE market share movement, any deviation in OPEX ratio from the 27–29% band, and whether physical AI customer engagements convert to backlog. The 5 backlog growth signals in the 10-K suggest this metric is already under management focus.